Kenya has received a Sh256 million ($2 million) grant from the Global Fund to support the nationwide distribution of Lenacapavir,…
Kenya has begun a new phase in its HIV prevention strategy with the introduction of Lenacapavir, a long-acting injectable pre-exposure…
Kenya has initiated a phased rollout of Lenacapavir, a long-acting injectable medicine for HIV prevention. The government’s action marks a…